Skip to main content
. 2022 Dec 9;8:131. doi: 10.1038/s41421-022-00496-x

Fig. 2. Antiviral activity of serum antibodies against pseudotyped SARS-CoV-2.

Fig. 2

a NAb titers against the pseudotyped SARS-CoV-2 Wuhan-1, Delta, Omicron BA.1 and BA.2 strains in the hybrid-immunity group at 1–3, 4–6, 7–9, and 10–12 months post vaccination, with the infection-only group serving as a control. The dotted line represents the limit of detection (1:5); below the limit of detection, values were set to 1:1. Error bars represent the GMT values (displayed as colored numbers in the figure) with a 95% confidence interval. Statistical significance was analyzed using the Kruskal–Wallis test. b Serum neutralizing activity measured as the GMT against the pseudotyped SARS-CoV-2 in the infection-only group and hybrid-immunity group (one, two, three, and all doses at 1–3 months post vaccination). cf The correlations between NAb titers (GMT) and Wuhan-1 (c), Delta (d), Omicron BA.1 (e), BA.2 (f) and RBD-IgG titers in the infection-only (left) and hybrid-immunity (right) groups. Scatter plots depict the simple linear fit with 95% confidence bands, together with the Spearman correlation coefficient and 2-tailed P value. Wuhan-1, SARS-CoV-2 Wuhan-Hu-1; MPV, months post vaccination.